Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology.
D000818:Animals; D002320:Cardiovascular Physiological Phenomena; D002986:Clinical Trials as Topic; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D009200:Myocardial Contraction / Q000187:drug effects; D015221:Potassium Channels / Q000187:drug effects; D017483:Receptors, Vasopressin / Q000737:chemistry / Q000187:drug effects / Q000502:physiology; D012772:Shock, Septic / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D014665:Vasodilator Agents; D014667:Vasopressins / Q000172:deficiency / Q000494:pharmacology / Q000627:therapeutic use*
D015221:Potassium Channels; D017483:Receptors, Vasopressin; D014665:Vasodilator Agents; D014667:Vasopressins